Lukachan, Gincy A.
Yadollahi, Azadeh
Auckley, Dennis
Gavrilovic, Bojan
Matelski, John
Chung, Frances
Singh, Mandeep
Article History
Received: 16 November 2022
Accepted: 30 June 2023
First Online: 13 July 2023
Declarations
:
: Ethics approval for this study was provided by Research Ethics Board at Toronto Western Hospital (Approval no. 14–8710.0) and Mount Sinai Hospital (Approval no. 11–0021-E) on June 23, 2011 and June 22, 2011 respectively. The study was registered in clinicaltrials.gov NCT02152202 on 02/06/2014. The study was also done as per the declaration of Helsinki. The benefits and purposes of the study were explained to the patients, and each participant provided written, informed consent. Confidentiality was maintained at all levels of the study by avoiding identifiers and using codes to identify patients. Participants’ involvement in the study was voluntary. Participants who did not wish to participate in the study or who wished to withdraw at any time were informed that they could do so without restriction.
: Not applicable.
: Frances Chung holds the ResMed Research Chair of Anesthesia, sleep and perioperative medicine, consultant to Takeda Pharma. STOP-Bang questionnaire proprietary to University Health Network.Mandeep Singh (MS) currently holds the Canadian Anesthesiologists’ Society Career Scientist Grant and a Merit award from the Department of Anesthesiology and Pain Medicine, University of Toronto (Toronto, Canada) to support academic time. MS also serves on the Medical Advisory Board of Hypersomnia Foundation (Atlanta, GA) on a voluntary basis.Gincy A Lukachan, Azadeh Yadollahi, Dennis Auckley, Bojan Gavrilovic, John Matelski: No competing interests.